Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Anticancer Research|January 18, 2003
Prognostic value of uPA, PAI-1 and PAI-2 mRNA expression in primary breast cancerFrederique Spyratos, Cecile Bouchet, Sengul Tozlu, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|January 30, 2020
Early metabolic response of breast cancer to neoadjuvant endocrine therapy: comparison to morphological and pathological responseSarah Boughdad, Laurence Champion, Veronique Becette, et al.Anticancer Research|August 19, 2007
Exemestane as neoadjuvant hormonotherapy for locally advanced breast cancer: results of a phase II trialMichele Tubiana-Hulin, Veronique Becette, Ivan Bieche, et al.Oncogene|May 18, 2005
Identification of molecular apocrine breast tumours by microarray analysisPierre Farmer, Herve Bonnefoi, Veronique Becette, et al.Gynecologic Oncology|March 12, 2026
Peritoneal cancer risk after risk reducing salpingo-oophorectomy, impact of mutational status and STIC lesionsClaire Saule, Enora Laas, Nina Weber, et al.Breast Cancer Research and Treatment|January 29, 2018
Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinomaAnne-Sophie Hamy, Giang-Thanh Lam, Enora Laas, et al.Cancer|June 18, 2016
Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial (UCBG 0609)Florence Lerebours, Sofia Rivera, Marie-Ange Mouret-Reynier, et al.Nature Medicine|March 6, 2023
Evolution of synchronous female bilateral breast cancers and response to treatmentAnne-Sophie Hamy, Judith Abécassis, Keltouma Driouch, et al.Pageof 1